Postal Ballot Notice Dtd February 21, 2026
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has issued a postal ballot notice seeking shareholder approval to appoint two new Independent Directors through special resolutions. The first resolution proposes appointing Mr. Preetmohinder Singh Bedi (PhD in Pharmaceutical Sciences, 28+ years of pharma research experience, Professor at Guru Nanak Dev University) for a 5-year term from January 1, 2026 to December 31, 2030. The second resolution proposes appointing Mr. Bhavesh Mahajan (Chartered Accountant, 19+ years of experience in audit, taxation, and corporate advisory) for a 5-year term from January 28, 2026 to January 27, 2031. Both appointments were recommended by the Nomination and Remuneration Committee, and the directors will only receive sitting fees, not full remuneration. E-voting through NSDL runs from February 27, 2026 to March 28, 2026, with results to be announced by March 30, 2026.
This is a routine corporate governance action with no direct financial impact on shareholders, as both new directors will only receive sitting fees. The appointments are required to meet SEBI's board composition norms and are unlikely to materially affect the stock price.